Biosensors for Carcinoembryonic Antigen Detection for Future Prospective: A Review

Authors

  • Sudheer Kumar JC OrthoHeal Private Limited Akota, Vadodara-390020, Gujarat, India, Vadodara-390020, Gujarat, India
  • Sukhila Krishnan Sahrdaya College of Engineering and Technology, Department of Applied Science and Humanities, Kodakara, Thrissur-680684, Kerala, India

DOI:

https://doi.org/10.37256/sce.4220233104

Keywords:

biosensor, carcinoembryonic antigen (CEA), detection, biomarker, diagnosis, cancer, diagnosis, application, biosensor detection

Abstract

Recently, the increasing incidence of cancer diseases has become a challenge for researchers, and many people have died from this cause. The primary solution for this disease is proper diagnosis and detection of Carcinoembryonic Antigen (CEA) in the human body system, which extensively reduces cancer mortality and saves lives. For that reason, the development of biosensor detection systems for CEA is mandatory because they are easy to utilize, handy, and can provide treatment in real time. The biosensors play a significant role in detecting early signs of disease. These can be employed for risk judgment, diagnosis, and prognosis, as well as for assessing treatment effectiveness, toxicity, and recurrence. This review article systematically presents a brief overview of the development of biosensors and the identification of CEA and its various types. Numerous approaches are used for the recognition of cancer biomarkers, such as label-free approach, electrochemical, mass-based transduction, and optical methods, along with analytical performance of several biosensors, while also exploring the unsolved difficulties and future challenges in the development of cancer biomarkers.

Downloads

Published

2023-08-03

How to Cite

(1)
Kumar, S.; Krishnan, S. Biosensors for Carcinoembryonic Antigen Detection for Future Prospective: A Review. SCE 2023, 4, 100-120.